Victory Capital Management Inc Angion Biomedica Corp. Transaction History

Victory Capital Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 07, 2022	SELL	$2.35 - $9.95 $180,574 - $764,558	-76,840 Closed	0 $0
Q3 2021 Nov 02, 2021	SELL	$9.31 - $13.25 $5,772 - $8,215	-620 Reduced 0.8%	76,840 $751,000
Q2 2021 Aug 03, 2021	SELL	$13.02 - $17.83 $67,183 - $92,002	-5,160 Reduced 6.25%	77,460 $1.01 Million
Q1 2021 May 04, 2021	BUY	$15.01 - $25.74 $1.24 Million - $2.13 Million	82,620 New	82,620 $1.49 Million

Ticker ANGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,113,300
Description
Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.